Nicotinamide or related metabolites have been reported to ameliorate the inflammatory response in NAFLD by regulating the TLR4 pathway (Zhuang et al., 2017). This evidence concerns the gene TLR4 and metabolic dysfunction-associated steatotic liver disease.